AuroLase Therapy

· Nanospectra Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AuroLase Therapy, covering 2016-11-03 to 2016-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors [NA]